Skip Navigation

European Heart Journal 1982 3(1):56-66;
Copyright © 1982 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by MANZ, M.
Right arrow Articles by LÜDERITZ, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MANZ, M.
Right arrow Articles by LÜDERITZ, B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1982 by The European Society of Cardiology

Electrophysiological effects of lorcainide in sinoatrial disease and in Wolff-Parkinson-White syndrome*

M. MANZ, G. STEINBECK and B. LÜDERITZ

Medizinische Klinik I, University of Munich, Klinikum Grofßhadern West Germany

Received 18 February 1981; revised 5 June 1981; .

Requests for reprints to: Dr med. M. Manz, Medizinische Klinik I. University of Munich, Klinikum GroBhadern, Marchioninistrasse 15, D-8000 Munchen 70. Federal Republic of Germany.

Abstract

The influence of lorcainide on sinus node function and intracardiac conduction was studied in 34 patients, including seven patients with sinoatrial disease and 14 patients with Wolff-Parkinson-White syndrome. Programmed cardiac stimulation and His bundle electrography were undertaken. Lorcainide, 2 mg/kg body weight, was given intravenously over a period of 10 min. In normal subjects, a slight increase of sinus rate was observed; lorcainide did not change corrected sinus node recovery time (CSNRT) and sinoatrial conduction time (SACT), calculated by use of the premature stimulus technique. In sinoatrial disease, however, three out of seven patients demon-strated a decrease of heart rate due to sinus node exit block, and CSNRT was markedly prolonged under the influence of the drug. Sinus node entrance block to premature atrial beats was observed in two controls and two patients with sinoatrial disease. Spontaneous sinus node exit block developed in two patients with sinoatrial dysfunction after administration of lorcainide. Refractory periods of the right atrium, right ventricle and conduction through the A V node (AH intervals) were unaffected by lorcainide, while HQ, QRS and QT intervals were prolonged. In Wolff-Parkinson-White syndrome, antegrade conduction via the accessory pathway was blocked in six out of 12 patients. After lorcainide, refractory periods of the accessory pathway increased in both the antegrade and retrograde direction. The ventricular rate during reciprocating tachycardia and during atrial fibril-lation was decreased by lorcainide. The results identify slowing of intraventricular conduction as the main action oflorcainide. In sinoatrial disease, lorcainide may aggravate sinus node dysfunction.

Key Words: Lorcainide • sinoatrial disease • Wolff-Parkinson-White syndrome


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.